From: Recurrent erysipelas - risk factors and clinical presentation
Single episode | Recurrent episode | OR (95% CI) from univariable analysis | p-value | OR (95% CI) from multivariable analysis1) | p-value | |
---|---|---|---|---|---|---|
n = 231 (100%) | n = 111 (100%) | (95% CI) | (95% CI) | |||
CABG | 11 (4.8) | 11 (9.7) | 2.2 (0.9-5.2) | 0.08 | 2.0 (0.8-5.1) | 0.12 |
Skin disease | 26 (11.3) | 23 (20.7) | 2.1 (1.1-3.8) | 0.02 | 1.9 (1.0-3.7) | 0.05 |
Severe obesity | 1 (0.4) | 4 (3.6) | 8.5 (0.9-77.9) | 0.06 | 4.6 (0.5-45.8) | 0.19 |
Venous insufficiency | 14 (6.1) | 16 (14.4) | 2.6 (1.2-5.6) | 0.02 | 2.3 (1.0-5.2) | 0.05 |
Lymphedema | 6 (2.6) | 9 (8.1) | 3.3 (1.1-9.5) | 0.03 | 4.3 (1.3-14.0) | 0.02 |
Local wound | 118 (51.1) | 49 (44.1) | 0.8 (0.5-1.2) | 0.23 | 0.8 (0.5-1.3) | 0.42 |
COPD | 15 (6.5) | 2 (1.8) | 0.3 (0.06-1.2) | 0.08 | 0.2 (0.04-1.0) | 0.05 |
Diabetes mellitus | 44 (19.1) | 20 (18.0) | 0.9 (0.5-1.7) | 0.82 | ||
Malignancy | 20 (8.7) | 14 (12.6) | 1.5 (0.7-3.1) | 0.29 | ||
Toe web intertrigo | 10 (4.3) | 8 (7.2) | 1.7 (0.7-4.5) | 0.27 | ||
Local operation2) | 49 (21.2) | 27 (24.3) | 1.2 (0.7-2.0) | 0.28 |